TrialEuropean urology2022

Molecular Genetic Determinants of Shorter Time on Active Surveillance in a Prospective Phase 2 Clinical Trial in Metastatic Renal Cell Carcinoma.

Oscar Reig Torras et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.